Mazzola, M. A., Raheja, R., Regev, K., Beynon, V., von Glehn, F., Paul, A., . . . Gandhi, R. (2019). Monomethyl fumarate treatment impairs maturation of human myeloid dendritic cells and their ability to activate T cells. Multiple sclerosis, 25(1), 63. https://doi.org/10.1177/1352458517740213
Citace podle Chicago (17th ed.)Mazzola, Maria Antonietta, et al. "Monomethyl Fumarate Treatment Impairs Maturation of Human Myeloid Dendritic Cells and Their Ability to Activate T Cells." Multiple Sclerosis 25, no. 1 (2019): 63. https://doi.org/10.1177/1352458517740213.
Citace podle MLA (9th ed.)Mazzola, Maria Antonietta, et al. "Monomethyl Fumarate Treatment Impairs Maturation of Human Myeloid Dendritic Cells and Their Ability to Activate T Cells." Multiple Sclerosis, vol. 25, no. 1, 2019, p. 63, https://doi.org/10.1177/1352458517740213.